Osteoporosis News

Postmenopausal women experienced more widespread vertebral bone accrual at the lumbar spine at 12 months of romosozumab treatment compared with teriparatide, according to study data published in the Journal of Bone and Mineral Research.

A cohort of postmenopausal women from Finland had a bone mineral density decrease of about 10% during a follow-up period of 25 years, according to findings published in the Journal of Bone and Mineral Research.

Despite potential side effects, bisphosphonate therapy may benefit postmenopausal women with osteoporosis by preventing fractures, according to a study published in JAMA Internal Medicine.

An effective way to predict a woman aged 25 to 31 years will develop osteoporosis is to do a check of sclerostin and possibly other blood serum markers for bone turnover at key timepoints in the woman’s life, according to a presenter.

NAMS has released a position statement reflecting the latest thinking and findings regarding the management of osteoporosis in postmenopausal women.

Absolute appendicular lean mass appears to be a suitable marker for predicting osteoporosis based on low muscle mass for postmenopausal women, according to findings published in Menopause.

Researchers found that osteoporosis and fracture were associated with certain lifestyle factors among postmenopausal women, although no factors correlated with an increase in both osteoporosis and fracture.

There is a link between cognitive decline and a faster rate of bone loss, and women who experienced cognitive decline over 5 years were at increased risk for fractures, researchers reported in the Journal of Bone and Mineral Research.

There is a bidirectional relationship between cognitive decline and accelerated bone loss with increased fracture risk among women, according to new data published in the Journal of Bone and Mineral Research.

Postmenopausal women with osteoporosis receiving romosozumab for 12 months had larger improvements in bone mineral density and bone strength at the lumbar spine compared with those receiving alendronate alone, according to study data.